A Multi-Center Retrospective Database Evaluation of Pediatric Subjects Diagnosed With Methemoglobinemia.

Background: Methemoglobinemia requires early identification and treatment, but limited knowledge exists regarding the current therapeutic approach taken by clinicians as well as the outcomes that occur in children. Objectives: To determine the current prevalence of this rare disease in the pediatric...

Descripción completa

Detalles Bibliográficos
Publicado en:Clinical Medicine Insights: Pediatrics pp. 1 - 10
Autores principales: Sinha, Neha, Lichak, Brooke, Thomas, Neal J, Krawiec, Conrad
Formato: research tables/charts Journal Article
Publicado: Sage Publications Inc. 9/19/2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=179767625&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 179767625
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        11795565
        B3KV
      jtl: Clinical Medicine Insights: Pediatrics
      issn: 11795565
      maglogo: Y
    pubinfo:
      dt: 9/19/2024
      pid: 20732
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        179767625
        179767625
        179767625
        10.1177/11795565241271678
        179767625
      ppf: 1
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: A Multi-Center Retrospective Database Evaluation of Pediatric Subjects Diagnosed With Methemoglobinemia.
      aug:
        au:
          Sinha, Neha
          Lichak, Brooke
          Thomas, Neal J
          Krawiec, Conrad
        affil: Pediatric Critical Care Medicine, Department of Pediatrics, Penn State Hershey Children's Hospital, Hershey, PA, USA
      sug:
        subj:
          Methemoglobinemia Epidemiology
          Hemoglobins Blood
          Methylene Blue Administration and Dosage
          Human
          Female
          Male
          Methemoglobinemia Mortality
          Multicenter Studies
          Retrospective Design
          Nonexperimental Studies
          Prospective Studies
          Electronic Health Records
          Disease Attributes
          Diagnosis, Laboratory
          Methemoglobinemia Diagnosis
          Funding Source
          Infant, Newborn
          Infant
          Child, Preschool
          Child
          Adolescence
          Metabolism, Inborn Errors
          Infant, Newborn: birth-1 month
          Infant: 1-23 months
          Child, Preschool: 2-5 years
          Child: 6-12 years
          Adolescent: 13-18 years
          Female
          Male
      ab: Background: Methemoglobinemia requires early identification and treatment, but limited knowledge exists regarding the current therapeutic approach taken by clinicians as well as the outcomes that occur in children. Objectives: To determine the current prevalence of this rare disease in the pediatric population, evaluate the impact of methemoglobin and functional hemoglobin levels, and assess how this disease is approached by clinicians. We hypothesize that methemoglobinemia prevalence is low and more methylene blue use would be observed in subjects with functional hemoglobin levels less than 7 g/dL. Design: This was a retrospective observational cohort study utilizing deidentified TriNetX® electronic health record (EHR) data. Methods: Using a multicenter EHR database, we evaluated subjective characteristics, diagnostic, laboratory results, medication, and procedural codes. Results: Ninety-eight children (mean age 5.3 ± 5.3 years) from 53 healthcare organizations were included. Methemoglobinemia prevalence was 0.0015% with an overall 30-day mortality of 6.1%. Subjects with methemoglobin percentages greater than 20% had a higher frequency of methylene blue administration (70.6% versus 24.7%, P =.0005). Critical care service requirements and methylene blue administration were similar in the subjects with functional hemoglobin less than 7 g/dL and more than 7 g/dL groups. Overall, 13 (13.2%) subjects underwent glucose-6-phosphate dehydrogenase deficiency (G6PD) testing. Conclusion: In our study, we found methemoglobinemia prevalence in children is low, there is a low frequency of G6PD testing despite methylene blue hemolysis risk, and subjects appeared to be treated similarly despite a low functional hemoglobin. These findings highlight the continued critical nature of this disease and may highlight opportunities for education aimed at improving care in children diagnosed with methemoglobinemia, particularly related to G6PD testing.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N